MedPath

Clinical observation of modified Buzhong Yiqi decoction combined with PKEP in the treatment of BPH with D

Phase 1
Conditions
Benign Prostatic Hyperplasia
Registration Number
ITMCTR2200006857
Lead Sponsor
Fangcun Hospital, Guangdong Provincial Hospital of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

1. Male aged 60-80 years old 2. The diagnosis conforms to the diagnostic criteria of western medicine and traditional Chinese medicine for benign prostatic hyperplasia, and urodynamics indicates that detrusor contractility is weak or no contraction (BCI < 100or Pdet@Qmax < 40cmH2O) 3.PSA, digital intestinal examination and imaging are not abnormal. Prostate cancer should be excluded by prostate puncture if there are abnormalities. 4. The patient agreed to participate in the trial and signed the informed consent form. 5. The American Society of Anesthesia score (ASA) was rated 1-3.

Exclusion Criteria

1. At present, it has been or will be included in other trials 2. The contractile force of detrusor is normal. Suffering from stress urinary incontinence, need to be treated or use a urine pad; 4. Suffering from urethral stricture or bladder neck obstruction; 5. History of prostate and bladder surgery; 6. Suffering from progressive malignant tumor or chronic consumptive disease; 7. The patient was complicated with severe cardiopulmonary disease or severe mental disorder. Combined with active infection; 9. Severe coagulation dysfunction

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of complications such as urinary incontinence;Success rate of catheter removal after operation;
Secondary Outcome Measures
NameTimeMethod
Residual urine;Profit rate;Maximum urinary flow rate;
© Copyright 2025. All Rights Reserved by MedPath